Herndon D N, Hart D W, Wolf S E, Chinkes D L, Wolfe R R
Department of Surgery, University of Texas Medical Branch, Shriners Hospitals for Children, Galveston 77550, USA.
N Engl J Med. 2001 Oct 25;345(17):1223-9. doi: 10.1056/NEJMoa010342.
The catecholamine-mediated hypermetabolic response to severe burns causes increased energy expenditure and muscle-protein catabolism. We hypothesized that blockade of beta-adrenergic stimulation with propranolol would decrease resting energy expenditure and muscle catabolism in patients with severe burns.
Twenty-five children with acute and severe burns (more than 40 percent of total body-surface area) were studied in a randomized trial. Thirteen received oral propranolol for at least two weeks, and 12 served as untreated controls. The dose of propranolol was adjusted to decrease the resting heart rate by 20 percent from each patient's base-line value. Resting energy expenditure and skeletal-muscle protein kinetics were measured before and after two weeks of beta-blockade (or no therapy, in controls). Body composition was measured serially throughout hospitalization.
Patients in the control group and the propranolol group were similar with respect to age, weight, percentage of total body-surface area burned, percentage of body-surface area with third-degree burns, and length of time from injury to metabolic study. Beta-blockade decreased the heart rates and resting energy expenditure in the propranolol group, both as compared with the base-line values (P<0.001 and P=0.01, respectively) and as compared with the values in the control group (P=0.03 and P=0.001, respectively). The net muscle-protein balance increased by 82 percent over base-line values in the propranolol group (P=0.002), whereas it decreased by 27 percent in the control group (P not significant). The fat-free mass, as measured by whole-body potassium scanning, did not change substantially in the propranolol group, whereas it decreased by a mean (+/-SE) of 9+/-2 percent in the control group (P=0.003).
In children with burns, treatment with propranolol during hospitalization attenuates hypermetabolism and reverses muscle-protein catabolism.
儿茶酚胺介导的对严重烧伤的高代谢反应会导致能量消耗增加和肌肉蛋白分解代谢。我们假设用普萘洛尔阻断β-肾上腺素能刺激会降低严重烧伤患者的静息能量消耗和肌肉分解代谢。
在一项随机试验中研究了25名急性重度烧伤(超过体表面积40%)的儿童。13名儿童接受口服普萘洛尔至少两周,12名儿童作为未治疗的对照组。调整普萘洛尔剂量以使静息心率从每个患者的基线值降低20%。在β受体阻滞剂治疗两周前和后(或对照组不进行治疗)测量静息能量消耗和骨骼肌蛋白动力学。在整个住院期间连续测量身体成分。
对照组和普萘洛尔组患者在年龄、体重、烧伤体表面积百分比、三度烧伤体表面积百分比以及从受伤到进行代谢研究的时间长度方面相似。与基线值相比(分别为P<0.001和P=0.01)以及与对照组的值相比(分别为P=0.03和P=0.001),β受体阻滞剂均降低了普萘洛尔组的心率和静息能量消耗。普萘洛尔组的净肌肉蛋白平衡比基线值增加了82%(P=0.002),而对照组则下降了27%(P无统计学意义)。通过全身钾扫描测量的去脂体重在普萘洛尔组中没有实质性变化,而在对照组中平均(±标准误)下降了9±2%(P=0.003)。
对于烧伤儿童住院期间用普萘洛尔治疗可减轻高代谢并逆转肌肉蛋白分解代谢。